Progress in research on prognosis-related gene mutations in diffuse large B-cell lym-phoma through next generation sequencing / 中国肿瘤临床
Chinese Journal of Clinical Oncology
; (24): 371-374, 2018.
Article
en Zh
| WPRIM
| ID: wpr-706810
Biblioteca responsable:
WPRO
ABSTRACT
Diffuse large B-cell lymphoma(DLBCL)is a highly invasive malignant lymphoma,and the molecular mechanism of its patho-genesis is not fully understood.Next generation sequencing(NGS)is an increasingly mature gene assay technology,which has been widely applied in recent years to study the genetics of DLBCL.Targeted therapy development has progressed significantly on the basis of these studies,which has made genetic mutations in DLBCL become the new research hotspot.This review summarizes the progress in research on progress-related gene mutations in DLBCL.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Prognostic_studies
Idioma:
Zh
Revista:
Chinese Journal of Clinical Oncology
Año:
2018
Tipo del documento:
Article